Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 40

Results For "MD"

2310 News Found

Sanplatec selects Mitsubishi Chemical’s Zelas TPS for new cell culture tubes
R&D | April 23, 2026

Sanplatec selects Mitsubishi Chemical’s Zelas TPS for new cell culture tubes

Sanplatec is leading the industry in the field of containers and devices for cell culture and live transport


Motorica India CRE programme enhances clinician training and patient-centric prosthetic care
Healthcare | April 23, 2026

Motorica India CRE programme enhances clinician training and patient-centric prosthetic care

Three-day programme focuses on advanced socket design, myoelectric technology and clinical skill development


Experts convene in India to push for urgent action on dengue treatment gaps
Public Health | April 23, 2026

Experts convene in India to push for urgent action on dengue treatment gaps

Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches


ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer
People | April 22, 2026

ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer

Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations


New guardian protein mechanism identified in aggressive skin cancer progression
R&D | April 22, 2026

New guardian protein mechanism identified in aggressive skin cancer progression

While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies


ECI taps industry veteran Khalid Raja to drive strategic growth
People | April 22, 2026

ECI taps industry veteran Khalid Raja to drive strategic growth

Move comes amid rising regulatory pressures


US FDA okays Merck's new once-daily HIV pill
Drug Approval | April 22, 2026

US FDA okays Merck's new once-daily HIV pill

The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir


Pfizer unleashes wave of breakthrough cancer data at ASCO 2026
R&D | April 22, 2026

Pfizer unleashes wave of breakthrough cancer data at ASCO 2026

Pharma giant targets new standards of care


Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push
Biopharma | April 22, 2026

Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push

The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform